According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...

Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. The prescription drugs market will grow from $1,240.33B in 2024 to $2,151.63B by ...

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

For Dr Alexandra Sowa, author of ‘The Ozempic Revolution’, getting onto GLP-1 drugs like Mounjaro or Ozempic is not a ...

Drugmakers are introducing discounts and lower-cost options for consumers who have to pay for GLP-1 drugs out of pocket. News outlets look at the trend in pricing for drugs like Wegovy and Zepbound.

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.